Overview
Today, WaveRider.ai detected 15 Continuation Breakout signals across the market. While the raw signal count suggests a busy trading day, the underlying market context requires a disciplined approach. The market is currently operating in a Cautious Regime with sentiment leaning Neutral to Bearish. Breadth is moderate at 53.5% above the SMA-40, but sector performance is highly divergent.
Quality Score: 3.5/5
Due to the Cautious regime, we apply a strict filter: only the highest-conviction setups with strong institutional backing or clear demand zone bounces receive a quality boost. We are seeing a heavy concentration in the Medical/Biotech sector (ARGX, AUTL, MIRM, TOI, BIIB), which is currently acting as a defensive theme amidst weakness in Consumer Discretionary and Utilities. Technology remains the top performer by ATR% (5.4%), but signals here are mixed with resistance challenges.
Traders should be selective. In a cautious environment, “buying the breakout” blindly is risky; we are looking for setups where price is interacting with high-strength demand zones or exhibiting exceptional volume relative to average (RVOL) to overcome market headwinds.
Top 5 Picks
MIRM ($109.16) — Medical / Revenue Biotech
Technical Setup: MIRM stands out as the highest-conviction setup of the day. The stock is printing a massive RVOL of 7.9, indicating significant institutional accumulation or aggressive momentum entry. Despite being in a “between” zone context, the price action is supported by a 4-hour demand zone with a strength of 6.5. With a 52-week low performance of +154.5%, the stock is in a clear long-term uptrend, making this a classic continuation play. The ATR%-M of 2.9 confirms expanding volatility in the direction of the move.
Institutional Backing: 489 funds (Bucket B0, B1). Moderate institutional interest, but the volume profile suggests fresh money entering.
| Level | Price |
|---|---|
| Entry | $109.50 – $110.50 |
| Stop Loss | $104.00 (Below recent swing low) |
| Target 1 | $118.00 |
| Target 2 | $125.00 |
GEN ($23.29) — Software / Computer Sftwr-Security
Technical Setup: GEN is a high-conviction Technology play in the leading sector (5.4% ATR). It is currently testing a 1-hour supply zone, but the RVOL of 1.7 and a 5.7% gain suggest a potential breakout attempt. Crucially, the stock has a massive demand zone below at $19.67-$20.19 with a strength of 7.9, providing a high-probability safety net if the breakout fails and retests support. The institutional backing is robust with 1946 funds.
Institutional Backing: 1946 funds (Bucket N/A – High Institutional Density).
| Level | Price |
|---|---|
| Entry | $23.70 (Break of 1h supply) |
| Stop Loss | $22.50 |
| Target 1 | $25.50 |
| Target 2 | $27.00 |
ZS ($152.43) — Software / Computer Sftwr-Security
Technical Setup: Similar to GEN, ZS is a Security software stock showing strength. It is currently at a 1-hour supply zone with a strength of 5.7, but the RVOL of 1.9 and a 4.3% gain indicate buyers are aggressive. The risk/reward is favorable because the nearest major demand zone (1h strength 8.3) is well below at $133.74. This setup offers a “breakout or deep bounce” opportunity, though the cautious regime suggests waiting for a confirmed close above $154.24.
Institutional Backing: 2011 funds (Bucket N/A).
| Level | Price |
|---|---|
| Entry | $154.50 |
| Stop Loss | $149.00 |
| Target 1 | $162.00 |
| Target 2 | $170.00 |
BIIB ($204.53) — Medical / Profitable Biotech
Technical Setup: BIIB is a defensive play in the Medical sector. It is sitting at a daily demand zone (strength 6.7) with a distance of 2.87%. While the RVOL is modest at 1.1, the 2.6% gain and proximity to a 52-week high (-0.7%) suggest it is ready to move. The massive institutional footprint of 2348 funds provides a floor for the price. In a cautious market, large-cap profitable biotech often outperforms speculative names.
Institutional Backing: 2348 funds (Bucket N/A – Heavy Institutional).
| Level | Price |
|---|---|
| Entry | $205.00 – $206.00 |
| Stop Loss | $195.00 |
| Target 1 | $215.00 |
| Target 2 | $225.00 |
GS ($955.42) — Banks / Money Center
Technical Setup: Goldman Sachs is trading in a “between” zone but is showing steady accumulation with an RVOL of 1.3 and a 1.0% gain. With a 52-week high of only -3.0%, the stock is in a tight consolidation near all-time highs. The lack of immediate supply overhead (Supply: null) and strong institutional backing (3535 funds) make this a low-risk continuation candidate. The ATR%-M of 3.6 suggests volatility is expanding.
Institutional Backing: 3535 funds (Bucket N/A).
| Level | Price |
|---|---|
| Entry | $958.00 |
| Stop Loss | $935.00 |
| Target 1 | $980.00 |
| Target 2 | $1010.00 |
Honorable Mentions
- ARGX ($802.70): High institutional count (841 funds) at a daily demand zone, though currently down 1.2%.
- HEI ($291.80): Aerospace/Defense sector leader with 1178 institutional funds, trading between zones with low volatility.
- TOI ($4.08): High RVOL (2.7) at a 1-hour demand zone, but high volatility risk (ADR 6.2%).
- SNOW ($152.37): Enterprise software with massive institutional backing (2208 funds), currently consolidating.
- AUTL ($1.71): Speculative biotech with high RVOL (1.5) but trading at a supply zone with zero institutional funds.
Strategy Summary
Today’s continuation setups are characterized by a distinct split: High-Volume Momentum in Biotech (MIRM) and Institutional Accumulation in Software and Finance (GEN, ZS, GS). The Cautious Regime dictates that we prioritize setups with strong demand zone support (BIIB, MIRM) or clear breakout confirmation above resistance (GEN, ZS).
Key sectors represented are Medical (defensive) and Software (growth). Risk management is paramount; given the bearish sentiment in Consumer Discretionary and Utilities, avoid chasing stocks in those sectors. Focus on the top 5 picks where the risk/reward ratio is optimized by either volume confirmation or institutional safety nets.